Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
uninsubria.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
☰
Pubblicazioni
LUNG CANCER
Rivista
Codice:
E103763
ISSN:
0169-5002
Dati Generali
Dati Generali
Pubblicazioni (27)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer
Articolo
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls
Articolo
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Articolo
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy
Articolo
Assessment of lung cancer mortality reduction after chest X-ray screening in smokers: A population-based cohort study in Varese, Italy
Articolo
Chest X-rays Lung Cancer Screening in Cigarette Smokers in the Province of Varese, Italy
Articolo
Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?
Articolo
Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain
Articolo
Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy
Articolo
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer
Articolo
EORTC QLQ-C30 summary score reliably detects changes in QoL three months after anatomic lung resection for Non-Small Cell Lung Cancer (NSCLC)
Articolo
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Articolo
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743
Articolo
Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in Italy
Articolo
Immune related adverse events and response to immunotherapy: Focus on corticosteroids
Articolo
Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines
Articolo
LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer
Articolo
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial
Articolo
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
Articolo
PERIOPERATIVE SEQUENTIAL DETERMINATIONS OF TUMOR MARKERS
Articolo
Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007)
Articolo
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer.
Articolo
Prognostic role of K-Ras mutations in non-small cell lung cancer: still an issue for open debate.
Articolo
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
Articolo
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.
Articolo
Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC
Articolo
Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001)
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
